A Study to Compare SB16 (Proposed Denosumab Biosimilar) to Prolia® in Postmenopausal Women With Osteoporosis

Clinical trial NCT04664959 · COMPLETED

Trial details

NCT number: NCT04664959
Sponsor: Samsung Bioepis Co., Ltd.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Postmenopausal Osteoporosis

Start date: 2020-11-26
Primary completion: 2022-06-20
Enrollment: 457

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.